Corrigendum: Lymphocytes in Cellular Therapy: Functional Regulation of CAR T Cells

Corrigendum: Lymphocytes in Cellular Therapy: Functional Regulation of CAR T Cells

Bibliographic Details
Main Authors:	Alka Dwivedi, Atharva Karulkar, Sarbari Ghosh, Afrin Rafiq, Rahul Purwar
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2019-03-01
Series:	Frontiers in Immunology
Subjects:	chimeric antigen receptor cancer immunotherapy immunoregulation anti-tumor efficacy cytokines
Online Access:	https://www.frontiersin.org/article/10.3389/fimmu.2019.00401/full

Similar Items

Lymphocytes in Cellular Therapy: Functional Regulation of CAR T Cells
by: Alka Dwivedi, et al.
Published: (2019-01-01)

CAR-NK cells: A promising cellular immunotherapy for cancer
by: Guozhu Xie, et al.
Published: (2020-09-01)

Current State of CAR T-Cell Therapy in Chronic Lymphocytic Leukemia
by: Veronika Mancikova, et al.
Published: (2021-05-01)

The Great War of Today: Modifications of CAR-T Cells to Effectively Combat Malignancies
by: Andriy Zhylko, et al.
Published: (2020-07-01)

CAR T-Cells in Multiple Myeloma: State of the Art and Future Directions
by: Luis Gerardo Rodríguez-Lobato, et al.
Published: (2020-07-01)

Efficacy and Safety of CAR-Modified T Cell Therapy in Patients with Relapsed or Refractory Multiple Myeloma: A Meta-Analysis of Prospective Clinical Trials
by: Xinrong Xiang, et al.
Published: (2020-12-01)

Construction and Functional Characterization of a Fully Human Anti-mesothelin Chimeric Antigen Receptor (CAR) Expressing T Cell
by: Leila Jafarzadeh, et al.
Published: (2020-06-01)

Differences in Expansion Potential of Naive Chimeric Antigen Receptor T Cells from Healthy Donors and Untreated Chronic Lymphocytic Leukemia Patients
by: Jean-Marc Hoffmann, et al.
Published: (2018-01-01)

Foreign or Domestic CARs: Receptor Ligands as Antigen-Binding Domains
by: Donald R. Shaffer, et al.
Published: (2014-01-01)

How Can We Engineer CAR T Cells to Overcome Resistance?
by: Glover M, et al.
Published: (2021-05-01)

Corrigendum: A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children’s Oncology Group Study ANBL0931
by: M. Fevzi Ozkaynak, et al.
Published: (2018-07-01)

The Role of Immunological Synapse in Predicting the Efficacy of Chimeric Antigen Receptor (CAR) Immunotherapy
by: Dongfang Liu, et al.
Published: (2020-08-01)

Tuning the performance of CAR T cell immunotherapies
by: Noah H. Richardson, et al.
Published: (2019-11-01)

Minicircle DNA-Mediated CAR T Cells Targeting CD44 Suppressed Hepatocellular Carcinoma Both in vitro and in vivo [Corrigendum]
by: Wang H, et al.
Published: (2020-06-01)

Chimeric Antigen Receptor (CAR) T Cell Therapy for Metastatic Melanoma: Challenges and Road Ahead
by: Tahereh Soltantoyeh, et al.
Published: (2021-06-01)

You Have Got a Fast CAR: Chimeric Antigen Receptor NK Cells in Cancer Therapy
by: Aline Pfefferle, et al.
Published: (2020-03-01)

A Metabolism Toolbox for CAR T Therapy
by: Xuequn Xu, et al.
Published: (2019-04-01)

A Small Number of HER2 Redirected CAR T Cells Significantly Improves Immune Response of Adoptively Transferred Mouse Lymphocytes against Human Breast Cancer Xenografts
by: Gábor Tóth, et al.
Published: (2020-02-01)

Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells
by: Mohamed-Reda Benmebarek, et al.
Published: (2019-03-01)

Development of CAR-T Cell Persistence in Adoptive Immunotherapy of Solid Tumors
by: Jiaqiao Fan, et al.
Published: (2021-01-01)

CD19 CAR-T cell therapy for relapsed/refractory acute lymphoblastic leukemia: factors affecting toxicities and long-term efficacies
by: Li-Na Zhang, et al.
Published: (2018-03-01)

Emerging Approaches for Regulation and Control of CAR T Cells: A Mini Review
by: Lærke J. B. Brandt, et al.
Published: (2020-02-01)

Relevant nursing measures for the adverse reactions associated with chimeric antigen receptor T cells (CAR-T) immunotherapy: a systematic review of case reports†
by: Zhang Xu, et al.
Published: (2019-07-01)

Controlling Cytokine Release Syndrome to Harness the Full Potential of CAR-Based Cellular Therapy
by: Monica S. Thakar, et al.
Published: (2020-01-01)

Advances in Universal CAR-T Cell Therapy
by: Haolong Lin, et al.
Published: (2021-10-01)

CAR T-cell immunotherapy of MET-expressing malignant mesothelioma
by: Thivyan Thayaparan, et al.
Published: (2017-12-01)

Seatbelts in CAR therapy: How Safe Are CARS?
by: Kentaro Minagawa, et al.
Published: (2015-05-01)

Critical factors in chimeric antigen receptor-modified T-cell (CAR-T) therapy for solid tumors
by: Yan LL, et al.
Published: (2018-12-01)

From CAR-T Cells to CAR-NK Cells: A Developing Immunotherapy Method for Hematological Malignancies
by: Hui Lu, et al.
Published: (2021-08-01)

PD-L1 chimeric costimulatory receptor improves the efficacy of CAR-T cells for PD-L1-positive solid tumors and reduces toxicity in vivo
by: Qibin Liao, et al.
Published: (2020-11-01)

Use of Cell and Genome Modification Technologies to Generate Improved “Off-the-Shelf” CAR T and CAR NK Cells
by: Michael A. Morgan, et al.
Published: (2020-08-01)

CAR-T cells: Early successes in blood cancer and challenges in solid tumors
by: Hassan Dana, et al.
Published: (2021-05-01)

CAR-T design: Elements and their synergistic function
by: Jayapriya Jayaraman, et al.
Published: (2020-08-01)

Reactions Related to CAR-T Cell Therapy
by: Lele Miao, et al.
Published: (2021-04-01)

Efficacy of Humanized Anti-BCMA CAR T Cell Therapy in Relapsed/Refractory Multiple Myeloma Patients With and Without Extramedullary Disease
by: Haobin Deng, et al.
Published: (2021-08-01)

CAR-NK Cell: A New Paradigm in Tumor Immunotherapy
by: Faroogh Marofi, et al.
Published: (2021-06-01)

Chimeric Antigen Receptor (CAR) T Cell Therapy for Malignant Pleural Mesothelioma (MPM)
by: Astero Klampatsa, et al.
Published: (2017-09-01)

Cellular Immunotherapy of Canine Cancer
by: Selamawit Addissie, et al.
Published: (2018-12-01)

Macrophage, the potential key mediator in CAR-T related CRS
by: Zhaonian Hao, et al.
Published: (2020-07-01)

Befriending the Hostile Tumor Microenvironment in CAR T-Cell Therapy
by: Lorenzo Lindo, et al.
Published: (2021-02-01)